Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

JAMA: The Journal of the American Medical Association

Volumn 274, Issue 8, 1995, Pages 626-631

  Albertsen, Peter C ^a   Kolon, Thomas F ^a   Fryback, Dennis G ^b   Storer, Barry E ^b   Fine, Judith ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029081776     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03530080042039     Document Type: Article

References (21)

1. Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med. 1993;119:914-923.
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994; 44:7-26.
3. Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet. 1994;343:251-254.
4. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE, for the Prostate Patient Outcomes Research Team. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. JAMA. 1993;269:2633-2636.
5. Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley AG Jr, Wennberg JE, for the Prostate Patient Outcomes Research Team. A structured literature review of treatment for localized prostate cancer. Arch Fam Med. 1993;2:487-493.
6. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE, for the Prostate Patient Outcomes Research Team. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 1993;269:2650-2658.
7. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-780.
8. Johanssen JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992;267:2191-2196.
9. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330: 242-248.
10. Greenfield S, Giovanni A, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Med Care. 1993;31:141-154.
11. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974; 27:387-404.
12. Charlson ME, Pompei P, Alex KL, MacKenzi CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
13. Concato J, Horowitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA. 1992;267:1077-1082.
14. Catalona WJ, Whitmore WF. New staging systems for prostate cancer. J Urol. 1989;142:1302-1304.
15. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. New York, NY: John Wiley & Sons Inc; 1980.
16. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328:1237-1243.
17. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548-552.
18. Cowen ME, Chartrand M, Weitzel WF. A Markov model of the natural history of prostate cancer. J Clin Epidemiol. 1994;47:3-21.
19. Beck JR, Kattan MN, Miles BJ. Critique of decision analysis for clinically localized prostate cancer. J Urol. 1994;152:1894-1899.
20. Mold JW, Holtgrave DR, Bisonni RS, Marley DS, Wright RA, Spann SJ. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. J Fam Pract. 1992;34:561-568.
21. Litwin MS, Hays RD, Fink A, et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-135.